**Core Concept**
Cholesterol synthesis, also known as the mevalonate pathway, is a complex biochemical process involving multiple enzymes and intermediates. The rate-limiting step in this pathway is crucial for regulating the overall production of cholesterol in the body.

**Why the Correct Answer is Right**
The rate-limiting step in cholesterol synthesis is the conversion of HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) to mevalonate by the enzyme HMG-CoA reductase. This step is critical because it is the slowest and most energy-requiring step in the pathway. HMG-CoA reductase is a key regulatory enzyme, and its activity is tightly controlled by various feedback mechanisms, including the availability of intermediates and the presence of hormones like insulin and thyroid hormone. The inhibition of HMG-CoA reductase by statins, a class of cholesterol-lowering drugs, further underscores the importance of this enzyme in regulating cholesterol synthesis.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the conversion of acetyl-CoA to HMG-CoA by acetoacetyl-CoA acetyltransferase is an early step in the pathway and is not the rate-limiting step.

**Option B:** This option is incorrect because the conversion of farnesyl pyrophosphate to squalene by squalene synthase is a later step in the pathway and is not the rate-limiting step.

**Option C:** This option is incorrect because the conversion of lanosterol to cholesterol by desmolase is a late step in the pathway and is not the rate-limiting step.

**Clinical Pearl / High-Yield Fact**
The inhibition of HMG-CoA reductase by statins leads to a decrease in the synthesis of not only cholesterol but also other important biomolecules, including coenzyme Q10 and dolichol.

**Correct Answer: D. HMG-CoA reductase**